Article info
Review
Medulloblastoma cancer stem cells: molecular signatures and therapeutic targets
- Correspondence to Professor Robert J Poppiti, Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach FL 33140, USA; Robert.Poppiti{at}msmc.com
Citation
Medulloblastoma cancer stem cells: molecular signatures and therapeutic targets
Publication history
- Received October 2, 2019
- Revised December 12, 2019
- Accepted December 16, 2019
- First published February 7, 2020.
Online issue publication
April 20, 2020
Article Versions
- Previous version (7 February 2020).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.